USEMX | VEIEX | USEMX / VEIEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 31 years | - |
Gain YTD | 0.448 | -0.857 | -52% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 504M | 109B | 0% |
Annual Yield % from dividends | 1.74 | 3.27 | 53% |
Returns for 1 year | 10.53 | 13.73 | 77% |
Returns for 3 years | -3.11 | -5.61 | 55% |
Returns for 5 years | 9.05 | 5.29 | 171% |
Returns for 10 years | 37.87 | 28.13 | 135% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LSMNX | 14.23 | 0.07 | +0.49% |
Loomis Sayles Small/Mid Cap Growth N | |||
WFPRX | 48.83 | 0.18 | +0.37% |
Allspring Special Mid Cap Value R6 | |||
HDOGX | 13.31 | 0.04 | +0.30% |
Hennessy Total Return Investor | |||
PCSMX | 15.35 | N/A | N/A |
Principal SmallCap Growth I R6 | |||
FBDIX | 118.54 | -0.14 | -0.12% |
Franklin Biotechnology Discovery A |